Friday, May 1, 2026

How South Korea Plans to Integrate Commercial Space Technology into Military Operations by 2026

SpaceX expands military space tech for Ukraine; South Korea's JCS seeks to integrate commercial capabilities for defense operations.

Discover Kakao’s Kanana: How AI is Transforming Daily Life at 2026 World IT Show

Kakao will showcase agentic AI at the 2026 IT Show, highlighting its integration in daily life through interactive experiences.

Report: North Korea Strengthens Ties With China, Russia Ahead of Key Party Anniversaries

North Korea aims for economic revival through ties with China and Russia, while cautious about U.S. relations and inter-Korean dialogue.

Tag: development

LG Chem’s FMC-220: A Breakthrough Cancer Drug Targeting the p53 Y220C Mutation

LG Chem secures exclusive rights to FMC-220, a cancer drug targeting the p53 Y220C mutation, aiming for Phase 1 trials.

Lunit and Selcarta Join Forces: Accelerating AI Biomarker Companion Diagnostics in 2026

Lunit partners with Selcarta to enhance AI-based biomarkers for diagnostics, aiming to streamline clinical trials and accelerate drug development.

FDA’s Game-Changing Guidelines: What Asian Biotech Firms Must Know About Clinical Trial Efficiency

Clinical Trial Design is crucial for success in pharma; FDA's new rules could ease burdens but raise quality standards.

National AI Strategy Committee Partners With Cisco on AI Security and Talent Development

The National AI Strategy Committee collaborates with Cisco on AI security and talent development, prioritizing a safe AI ecosystem.

Matica Biotechnologies Signs Adenovirus Therapy CDMO Deal With North American Research Institution

CHA Biotech's U.S. subsidiary, Matica Biotechnologies, secures a CDMO agreement for adenovirus therapy with a major North American institution.

How the Late Lee Kun-hee’s 700 Billion Won Donation is Transforming Infectious Disease Research in Korea

The KDCA will host two international symposia on infectious disease research to enhance collaboration and response capabilities starting March 26.

Is VRN110755 the Future of Non-Small Cell Lung Cancer Treatment? Find Out!

Voronoi's VRN110755 for NSCLC receives approval for clinical trial modifications, expanding to a Phase 1b/2 trial across multiple regions.

KT Partners with KOSA to Elevate AI Certification Standards in 2026

KT partners with KOSA to enhance AI literacy and improve the AICE certification, aiming to cultivate industry-relevant AI talent.

How 80% Faster AI Analysis is Revolutionizing Healthcare

Koo Hyuk-jae visits BioNexus to explore AI's role in biomedical research, aiming to revolutionize drug development and diagnostics.

How GCCL and KBIOHealth’s New Agreement Will Transform Clinical Trials in South Korea

GCCL signs MOU with KBIOHealth to enhance clinical research and drug development, integrating public research with industry expertise.

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Verismo Therapeutics Welcomes FDA Approval Expert Dennis Williams: What This Means for CAR-T Cell Therapy

HLB Innovation appoints Dr. Dennis Williams as VP of Regulatory Affairs at Verismo Therapeutics to enhance global regulatory strategies.

Discover the Legacy: Hanmi Group Unveils Monument Honoring Founder Lim Seong-ki

Hanmi Group honors founder Lim Seong-ki with a bronze sculpture, celebrating his legacy in pharmaceutical innovation and drug development.

Glass Substrate Rival? This New Ceramic Package Is Credit-Card Thin (0.008 in.) With Near-Zero Warping

Korea Ceramic Technology Institute develops ultra-thin ceramic semiconductor substrate, enhancing AI signal processing and efficiency.

Top News

- Our Sponsors Ad -

Follow us